FDA Inspection 1173907 — Grifols Bio Supplies Inc.
The FDA completed an inspection of Grifols Bio Supplies Inc. on Jun 28, 2022 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 28, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Baltimore, MD (United States)